Cargando…
Clinical Features of Patients Undergoing the Head-Up Tilt Test and Its Safety and Efficacy in Diagnosing Vasovagal Syncope in 4,873 Patients
Background: The head-up tilt test (HUTT) is a useful diagnostic tool in patients with suspected vasovagal syncope (VVS). Objectives: We aimed to investigate the direct drug-potentiated HUTT in patients with recurrent syncope or precursor syncope and to assess the diagnostic value of the direct drug-...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8790085/ https://www.ncbi.nlm.nih.gov/pubmed/35097001 http://dx.doi.org/10.3389/fcvm.2021.781157 |
_version_ | 1784639914194763776 |
---|---|
author | Xu, Lingping Cao, Xiangqi Wang, Rui Duan, Yichao Yang, Ye Hou, Junlong Wang, Jing Chen, Bin Xue, Xianjun Zhang, Bo Ma, Hua Sun, Chaofeng Guo, Fengwei |
author_facet | Xu, Lingping Cao, Xiangqi Wang, Rui Duan, Yichao Yang, Ye Hou, Junlong Wang, Jing Chen, Bin Xue, Xianjun Zhang, Bo Ma, Hua Sun, Chaofeng Guo, Fengwei |
author_sort | Xu, Lingping |
collection | PubMed |
description | Background: The head-up tilt test (HUTT) is a useful diagnostic tool in patients with suspected vasovagal syncope (VVS). Objectives: We aimed to investigate the direct drug-potentiated HUTT in patients with recurrent syncope or precursor syncope and to assess the diagnostic value of the direct drug-potentiated HUTT. Methods: The medical history and direct drug-potentiated HUTT records of patients who complained of syncope or precursor syncope and who visited The Xianyang Central Hospital from January 2016 to December 2020 were retrospectively reviewed. Results: A total of 4,873 patients (age = 43.8 ± 17.6 years; male = 2,064 [42.4%]) were enrolled in our study. Overall, 2,343 (48.1%) showed positive responses as follows: 1,260 (25.9%) with the mixed type, 34 (0.7%) with the cardioinhibitory type, 580 (11.9%) with the vasodepressor type, 179 (3.7%) with postural tachycardia syndrome (POTS), and 290 (6.0%) with orthostatic hypotension (OH). The study showed that prior to syncope or near-syncope symptoms, patients first presented an increase in heart rate (HR), followed by decreases in blood pressure (BP) and HR successively. Among the patients in the syncope group, the sensitivity of the HUTT was 65.9%, which was significantly higher than a sensitivity of 44.8% for patients in the non-syncope group (P < 0.01). The sensitivity of the HUTT was higher for females than males in both the syncope group (52.6% in males and 77.9% in females, P < 0.01) and the non-syncope group (36.5% in males and 50.6% in females, P < 0.01). Within the four age groups (<20, 21–40, 41–60, and >60 years old), the sensitivities were 74.7%, 67.7%, 45.6%, and 31.2%, respectively. And all gender, age and symptom (whether suffered from a syncope or not) significantly affected the positive responses of HUTT. There were two adverse events and no deaths during the HUTT in this study. Conclusion: The direct drug-potentiated HUTT is a safe and highly sensitive tool with which to diagnose VVS. Patients with precursor syncope symptoms without syncope should undergo a HUTT, especially young females presenting with weakness and sweating, which can decrease the probability of a misdiagnosis or a missed diagnosis. |
format | Online Article Text |
id | pubmed-8790085 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-87900852022-01-27 Clinical Features of Patients Undergoing the Head-Up Tilt Test and Its Safety and Efficacy in Diagnosing Vasovagal Syncope in 4,873 Patients Xu, Lingping Cao, Xiangqi Wang, Rui Duan, Yichao Yang, Ye Hou, Junlong Wang, Jing Chen, Bin Xue, Xianjun Zhang, Bo Ma, Hua Sun, Chaofeng Guo, Fengwei Front Cardiovasc Med Cardiovascular Medicine Background: The head-up tilt test (HUTT) is a useful diagnostic tool in patients with suspected vasovagal syncope (VVS). Objectives: We aimed to investigate the direct drug-potentiated HUTT in patients with recurrent syncope or precursor syncope and to assess the diagnostic value of the direct drug-potentiated HUTT. Methods: The medical history and direct drug-potentiated HUTT records of patients who complained of syncope or precursor syncope and who visited The Xianyang Central Hospital from January 2016 to December 2020 were retrospectively reviewed. Results: A total of 4,873 patients (age = 43.8 ± 17.6 years; male = 2,064 [42.4%]) were enrolled in our study. Overall, 2,343 (48.1%) showed positive responses as follows: 1,260 (25.9%) with the mixed type, 34 (0.7%) with the cardioinhibitory type, 580 (11.9%) with the vasodepressor type, 179 (3.7%) with postural tachycardia syndrome (POTS), and 290 (6.0%) with orthostatic hypotension (OH). The study showed that prior to syncope or near-syncope symptoms, patients first presented an increase in heart rate (HR), followed by decreases in blood pressure (BP) and HR successively. Among the patients in the syncope group, the sensitivity of the HUTT was 65.9%, which was significantly higher than a sensitivity of 44.8% for patients in the non-syncope group (P < 0.01). The sensitivity of the HUTT was higher for females than males in both the syncope group (52.6% in males and 77.9% in females, P < 0.01) and the non-syncope group (36.5% in males and 50.6% in females, P < 0.01). Within the four age groups (<20, 21–40, 41–60, and >60 years old), the sensitivities were 74.7%, 67.7%, 45.6%, and 31.2%, respectively. And all gender, age and symptom (whether suffered from a syncope or not) significantly affected the positive responses of HUTT. There were two adverse events and no deaths during the HUTT in this study. Conclusion: The direct drug-potentiated HUTT is a safe and highly sensitive tool with which to diagnose VVS. Patients with precursor syncope symptoms without syncope should undergo a HUTT, especially young females presenting with weakness and sweating, which can decrease the probability of a misdiagnosis or a missed diagnosis. Frontiers Media S.A. 2022-01-12 /pmc/articles/PMC8790085/ /pubmed/35097001 http://dx.doi.org/10.3389/fcvm.2021.781157 Text en Copyright © 2022 Xu, Cao, Wang, Duan, Yang, Hou, Wang, Chen, Xue, Zhang, Ma, Sun and Guo. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Cardiovascular Medicine Xu, Lingping Cao, Xiangqi Wang, Rui Duan, Yichao Yang, Ye Hou, Junlong Wang, Jing Chen, Bin Xue, Xianjun Zhang, Bo Ma, Hua Sun, Chaofeng Guo, Fengwei Clinical Features of Patients Undergoing the Head-Up Tilt Test and Its Safety and Efficacy in Diagnosing Vasovagal Syncope in 4,873 Patients |
title | Clinical Features of Patients Undergoing the Head-Up Tilt Test and Its Safety and Efficacy in Diagnosing Vasovagal Syncope in 4,873 Patients |
title_full | Clinical Features of Patients Undergoing the Head-Up Tilt Test and Its Safety and Efficacy in Diagnosing Vasovagal Syncope in 4,873 Patients |
title_fullStr | Clinical Features of Patients Undergoing the Head-Up Tilt Test and Its Safety and Efficacy in Diagnosing Vasovagal Syncope in 4,873 Patients |
title_full_unstemmed | Clinical Features of Patients Undergoing the Head-Up Tilt Test and Its Safety and Efficacy in Diagnosing Vasovagal Syncope in 4,873 Patients |
title_short | Clinical Features of Patients Undergoing the Head-Up Tilt Test and Its Safety and Efficacy in Diagnosing Vasovagal Syncope in 4,873 Patients |
title_sort | clinical features of patients undergoing the head-up tilt test and its safety and efficacy in diagnosing vasovagal syncope in 4,873 patients |
topic | Cardiovascular Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8790085/ https://www.ncbi.nlm.nih.gov/pubmed/35097001 http://dx.doi.org/10.3389/fcvm.2021.781157 |
work_keys_str_mv | AT xulingping clinicalfeaturesofpatientsundergoingtheheaduptilttestanditssafetyandefficacyindiagnosingvasovagalsyncopein4873patients AT caoxiangqi clinicalfeaturesofpatientsundergoingtheheaduptilttestanditssafetyandefficacyindiagnosingvasovagalsyncopein4873patients AT wangrui clinicalfeaturesofpatientsundergoingtheheaduptilttestanditssafetyandefficacyindiagnosingvasovagalsyncopein4873patients AT duanyichao clinicalfeaturesofpatientsundergoingtheheaduptilttestanditssafetyandefficacyindiagnosingvasovagalsyncopein4873patients AT yangye clinicalfeaturesofpatientsundergoingtheheaduptilttestanditssafetyandefficacyindiagnosingvasovagalsyncopein4873patients AT houjunlong clinicalfeaturesofpatientsundergoingtheheaduptilttestanditssafetyandefficacyindiagnosingvasovagalsyncopein4873patients AT wangjing clinicalfeaturesofpatientsundergoingtheheaduptilttestanditssafetyandefficacyindiagnosingvasovagalsyncopein4873patients AT chenbin clinicalfeaturesofpatientsundergoingtheheaduptilttestanditssafetyandefficacyindiagnosingvasovagalsyncopein4873patients AT xuexianjun clinicalfeaturesofpatientsundergoingtheheaduptilttestanditssafetyandefficacyindiagnosingvasovagalsyncopein4873patients AT zhangbo clinicalfeaturesofpatientsundergoingtheheaduptilttestanditssafetyandefficacyindiagnosingvasovagalsyncopein4873patients AT mahua clinicalfeaturesofpatientsundergoingtheheaduptilttestanditssafetyandefficacyindiagnosingvasovagalsyncopein4873patients AT sunchaofeng clinicalfeaturesofpatientsundergoingtheheaduptilttestanditssafetyandefficacyindiagnosingvasovagalsyncopein4873patients AT guofengwei clinicalfeaturesofpatientsundergoingtheheaduptilttestanditssafetyandefficacyindiagnosingvasovagalsyncopein4873patients |